miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN

被引:16
作者
Du, Wei [1 ]
Zhang, Xu [1 ]
Wan, Zhen [2 ]
机构
[1] Nanchang Univ, Sch Queen Mary, Dept Clin Med, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Dept Gen Surg, Affiliated Hosp 1, Nanchang 33006, Jiangxi, Peoples R China
关键词
miR-3691-5p; hepatocellular carcinoma; PTEN; PI3K/Akt; migration; invasion; CANCER STATISTICS; EXPRESSION; PROGRESSION; CHINA;
D O I
10.2147/OTT.S208127
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: The enhanced ability of cancer metastasis is the major cause for the cancer-related death of hepatocellular carcinoma (HCC). Better understanding the mechanisms for the motility of cancer cells will benefit the treatment. Accumulating evidence suggests that aberrant microRNA (miRNA) expression contributes to HCC development and progression, whereas miR-3691-5p has not been reported in HCC. Purpose: The aim of this study was to elucidate the expression, function and mechanism of miR-3691-5p in HCC. Methods: Real-time quantitative polymerase chain reaction (qPCR) was performed to detect miR-3691-5p expression in HCC tissues and cell lines database analysis were conducted for detection of the expression of miR-3691-5p in HCC. Then, the association of miR-3691-5p with clinicopathological features of HCC patients were statistically measured. Subsequently, we attempted to observe the effects of miR-3691-5p on migration and invasion of HCC cells by transwell assays. Furthermore, bioinformatics tools and luciferase reporter gene assay as well as recuse experiments were conducted to explore the target of miR-3691-5p in HCC, and to explore whether the target mediated the effects of miR-3691-5p HCC cells. Results: In the current study, we found that miR-3691-5p expression was elevated in both HCC tissues and cell lines, which was significantly correlated with poor prognosis and clinicopathological features including TNM stage (P=0.016) and vascular invasion (P=0.016). Furthermore, gain-or loss-of function assays demonstrated that miR-3691-5p promoted HCC cell migration and invasion. Luciferase reporter assay confirmed that PTEN was a direct downstream target of miR-3691-5p. Recuse assays showed that restoration of PTEN reversed the effects of miR-3691-5p on HCC cell migration and invasion through decreasing PI3K/Akt signaling. Conclusion: Our results demonstrated that miR-3691-5p contributes to HCC cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN.
引用
收藏
页码:4897 / 4905
页数:9
相关论文
共 34 条
[1]   MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway [J].
Bao, Jie ;
Yu, Yan ;
Chen, Jianan ;
He, Yuting ;
Chen, Xiaolong ;
Ren, Zhigang ;
Xue, Chen ;
Liu, Liwen ;
Hu, Qiuyue ;
Li, Juan ;
Cui, Guangying ;
Sun, Ranran .
CELL DEATH & DISEASE, 2018, 9
[2]   PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3 [J].
Benitez, Jorge A. ;
Ma, Jianhui ;
D'Antonio, Matteo ;
Boyer, Antonia ;
Camargo, Maria Fernanda ;
Zanca, Ciro ;
Kelly, Stephen ;
Khodadadi-Jamayran, Alireza ;
Jameson, Nathan M. ;
Andersen, Michael ;
Miletic, Hrvoje ;
Saberi, Shahram ;
Frazer, Kelly A. ;
Cavenee, Webster K. ;
Furnari, Frank B. .
NATURE COMMUNICATIONS, 2017, 8
[3]   PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy [J].
Bian, X. ;
Gao, J. ;
Luo, F. ;
Rui, C. ;
Zheng, T. ;
Wang, D. ;
Wang, Y. ;
Roberts, T. M. ;
Liu, P. ;
Zhao, J. J. ;
Cheng, H. .
ONCOGENE, 2018, 37 (03) :341-351
[4]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[5]   Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway [J].
Dou, Changwei ;
Zhou, Zhenyu ;
Xu, Qiuran ;
Liu, Zhikui ;
Zeng, Yuqun ;
Wang, Yufeng ;
Li, Qing ;
Wang, Liang ;
Yang, Wei ;
Liu, Qingguang ;
Tu, Kangsheng .
ONCOGENE, 2019, 38 (08) :1239-1255
[6]   Hepatocellular carcinoma [J].
Forner, Alejandro ;
Reig, Maria ;
Bruix, Jordi .
LANCET, 2018, 391 (10127) :1301-1314
[7]   Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches [J].
Greten, Tim F. ;
Wang, Xin W. ;
Korangy, Firouzeh .
GUT, 2015, 64 (05) :842-848
[8]   The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo [J].
Huse, Jason T. ;
Brennan, Cameron ;
Hambardzumyan, Dolores ;
Wee, Boyoung ;
Pena, John ;
Rouhanifard, Sara H. ;
Sohn-Lee, Cherin ;
le Sage, Carlos ;
Agami, Reuven ;
Tuschl, Thomas ;
Holland, Eric C. .
GENES & DEVELOPMENT, 2009, 23 (11) :1327-1337
[9]   Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013 [J].
Islami, F. ;
Chen, W. ;
Yu, X. Q. ;
Lortet-Tieulent, J. ;
Zheng, R. ;
Flanders, W. D. ;
Xia, C. ;
Thun, M. J. ;
Gapstur, S. M. ;
Ezzati, M. ;
Jemal, A. .
ANNALS OF ONCOLOGY, 2017, 28 (10) :2567-2574
[10]  
Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]